slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 11,641-11,670
Pages 3,225
Rows per page 30
Component
11,641-11,670 of 96,741
36
The slide uses a red box to highlight the source text and an arrow to emphasize the aggressive quote.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
53
Uses a 'quote-counter-quote' structure to expose the contradiction.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
61
The slide uses a screenshot of a Quantumscape presentation and overlays red arrows to highlight the 'broken' lines in the chart, indicating a pulse test.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
67
Includes a quote from an unnamed expert and a screenshot of a QuantumScape presentation slide with added annotations.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
70
The slide uses a 'red flag' framing to question the transparency of the company's data reporting.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
81
The slide uses a 'red box' annotation technique to highlight specific text in the source material.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
82
Uses a screenshot of a competitor's slide to highlight a discrepancy in testing methodology.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
86
The slide uses a Q&A format to highlight the contradiction between the company's presented data and the expected physical behavior of the battery technology.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
99
The slide uses a screenshot of a Quantumscape presentation to point out the discrepancy between lab-scale testing and commercial requirements.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
103
Uses expert testimony to debunk specific technical claims made by a competitor (QS).QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
105
The slide uses a screenshot of a competitor's presentation with red annotations to highlight perceived inconsistencies.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
108
The slide includes a screenshot of a QuantumScape presentation slide with added red annotations to highlight the alleged deception.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
111
The slide uses a screenshot of a CellPress checklist to prove that the company's data presentation is non-compliant with industry best practices.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
125
The slide uses a red box to draw attention to the specific text in the source document.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
129
The slide uses a combination of expert quote and academic citation to frame the company's claims as fraudulent.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
133
The slide uses red annotations and arrows to highlight the lack of comprehensive data in QuantumScape's Q4 2020 shareholder letter.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
136
The slide uses a red arrow and annotation to point out the small sample size in the provided chart.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
162
Uses a screenshot of a Medium article to provide external validation for the claim of systemic fraud.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction2 hits
163
Uses a specific analogy to biotech (Phase 3 success vs. rodent data) to frame the technical limitation as a deceptive practice.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction2 hits
172
Uses a quote from Steve LeVine (Quartz) and a photo of Obama with Sakti3 founder to establish credibility and highlight the 'hype' narrative.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction2 hits
01
This is a classic activist short-seller cover page, utilizing aggressive, emotionally charged language to frame the thesis.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
18
The slide uses a Q&A format to build a case for the 'two-hit' hypothesis regarding drug interactions.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
19
The slide uses a combination of narrative description and citations of medical literature to establish the 'villain' (diazoxide) as dangerous.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
38
The slide uses an excerpt from the FDA label to critique the clinical trial design.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
50
Includes links to cached PDF documents as evidence of data discrepancy.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
105
The slide uses a direct comparison of drug mechanisms to challenge the target company's safety claims.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
108
The slide uses a screenshot of an FDA Medication Guide to contrast with the claim that DKA is missing from clinical literature.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
119
The slide uses a red box to highlight the specific comparison between placebo and pooled data at week 13.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
124
The slide uses a red box to highlight the specific claim about 60% of participants having PD/DM at baseline.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
05
The slide is a text-heavy regulatory filing page, likely part of a petition or formal complaint. It uses numbered points to build a case of scientific misconduct.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Problem & Complication2 hits